NPPB and congestive heart failure: Copeptin was reported to be a good predictor of all-cause mortality (RR 2.64, 95% CI 2.09–3.32) with a performance comparable to that of NT-proBNP in a meta-analysis of 4473 patients with acute and chronic heart failure [70].